Cassano D Adda

Researchers are evaluating the effectiveness of LightForce4 Therapy Lasers in reducing pain for people with acute grade I to II lateral ankle sprains. This international, multi-center, prospective, randomized, sham-controlled, single-blind study also collects post-market clinical data to assess the safety and performance of LightForce4 Therapy Lasers when used as intended in normal clinical practice. Participants receive either LightForce4 Therapy Lasers or sham laser therapy over 4 consecutive weeks. The treatment schedule includes at least 3 sessions per week for the first 2 weeks and at least 2 sessions per week for the following 2 weeks. All participants follow the standard care protocol including daily RICE (rest, ice, compression, elevation) at home for the first 2 weeks, and a physiotherapy/exercise program with 2 sessions per week at the site for 4 weeks. During the study, participants report their pain levels using a visual analog scale (VAS) at baseline and 2 weeks after starting treatment to measure pain change. Researchers monitor safety and performance throughout and collect data on adherence to the exercise and RICE protocols. The total study duration covers at least 4 weeks of treatment with follow-up to evaluate pain reduction and device safety.

Researchers are evaluating the effectiveness of LightForce Therapy Lasers combined with standard physiotherapy and exercise programs for reducing pain in people with shoulder soft tissue inflammation caused by Subacromial Impingement Syndrome (SAIS) or Rotator Cuff Tendinopathy (RCT). This is a post-market, international, multi-center, randomized, sham-controlled, single-blind study designed to assess both the performance and safety of LightForce Therapy Lasers as used in normal clinical practice, in compliance with medical device regulations. The goal is to compare the laser therapy plus standard care against a sham laser plus standard care in reducing shoulder pain.